15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 7 firms covering Connect Biopharma Holdings Ltd, 7 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets range widely, $4.00 to $10.00 (about 2.5x), a sign of real disagreement on valuation. The average target of $7.29 sits 247% above the current $2.10. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 3 to 7 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.28 next quarter toward $-0.94 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS7 ratings
Moderate Buy
Strong Buy00%
Buy7100%
Hold00%
Sell00%
Strong Sell00%
Based on 7 analysts giving stock ratings to Connect Biopharma Holdings Ltd.
As of Jul, 7 of 7 firms rate CNTB a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
CNTB EPS & revenue forecast
EPS · NEXT QUARTER
$-0.28
Range $-0.33 – $-0.25 · 6 analysts · -11% YoY
Next period, 6 analysts expect Connect Biopharma Holdings Ltd to earn $-0.28 a share (range $-0.33 – $-0.25), versus $-0.31 a year earlier. Full-year consensus is $-1.06, growing to $-0.94 the year after.
REVENUE · NEXT QUARTER
$4.4M
Range $0 – $34.0M · 6 analysts · +3780% YoY
Revenue is expected to reach $4.4M (range $0 – $34.0M), +3780.1% year-over-year. Full-year consensus is $41.8M, rising to $75.1M next year.
Top analysts covering Connect Biopharma Holdings Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on CNTB.
#1
Emily Bodnar
HC Wainwright & Co. · Rank #338
Buy
$8.00+281.0% to target
Overall win rate
22%
+ Follow
#2
Julian Harrison
BTIG
Buy
$10.00+376.2% to target
Coverage
—
+ Follow
#3
BF
Brandon Folkes
HC Wainwright & Co.
Buy
$7.00+233.3% to target
Coverage
—
+ Follow
#4
OB
Olivia Brayer
Cantor Fitzgerald
Buy
$4.00+90.5% to target
Coverage
—
+ Follow
#5
TF
Thomas Flaten
Lake Street
Buy
$9.00+328.6% to target
Coverage
—
+ Follow
CNTB stock forecast FAQ
What is CNTB's average 12-month price target?+
The 7 analysts with a live target average $7.29 for Connect Biopharma Holdings Ltd over the next 12 months, ranging from a $10.00 high to a $4.00 low.
Is CNTB stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 7 analyst ratings, 7 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for CNTB?+
The Street-high target is $10.00 (BTIG), and the Street-low is $4.00 (Cantor Fitzgerald). The average of all 7 active targets is $7.29.
How many Wall Street analysts cover CNTB?+
7 analysts have an active rating on Connect Biopharma Holdings Ltd, and 7 firms carry a live 12-month price target.
Who is the most accurate analyst covering CNTB?+
Among analysts who currently cover CNTB, Emily Bodnar of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #338). Their current call is Buy with a $8.00 target.
What is Connect Biopharma Holdings Ltd's projected EPS for next quarter?+
The consensus estimate is $-0.28 per share (range $-0.33 – $-0.25) across 6 analysts. Full-year EPS is projected at $-1.06, rising to $-0.94 the following year.
How much revenue is Connect Biopharma Holdings Ltd expected to report next quarter?+
Consensus revenue is $4.4M (range $0 – $34.0M). Full-year revenue is projected at $41.8M, growing to $75.1M next year.
Have analysts been upgrading or downgrading CNTB lately?+
As of Jul, 7 of 7 firms rate CNTB a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their CNTB calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
Oppenheimer
